Products
Solutions For
- - - Life Sciences
    - Diagnostics
News & Resources
Company
Contact
Demo Concentriq

Products
Solutions For
- - - Life Sciences
    - Diagnostics
News & Resources
Company
Contact
Demo Concentriq

[Event] European Congress of Pathology 2023

By Proscia | August 9, 2023

Featured Story:

70% Of Major Pharmaceutical Companies And CROs Surveyed Have Adopted Digital Pathology

June 13, 2023

70% Of Major Pharmaceutical Companies And CROs Surveyed Have Adopted Digital Pathology

Latest Articles

August 24, 2023

The Significance of Robust Validation in Automated Quality Control Solutions

July 11, 2023

Introducing Customized Sensitivity for Automated Quality Control

July 5, 2023

Five Steps to Firmly and Transparently Lead Your Digitization Journey

We’re on a mission to perfect cancer diagnosis with intelligent software that changes the way the world practices pathology. Join us.

Digital Pathology Platform
Concentriq for Research
Concentriq Dx
Computational Pathology

About Proscia
Careers
Contact
Privacy

1700 Market Street,
23rd Floor
Philadelphia, PA 19103

© Copyright 2023. Proscia Inc. Proscia, Concentriq and DermAI are trademarks or registered trademarks owned by Proscia Inc. All rights reserved.

CE marking Concentriq Dx is CE-marked under IVDR and is available for primary diagnosis in the US under the Covid-19 enforcement policy for remote pathology devices.

Proscia's AI applications are available for research use only.

Our website uses cookies. By using this site, you agree to its use of cookies.